Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity
Condition(s):Hepatitis B, ChronicLast Updated:September 14, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Hepatitis B, ChronicLast Updated:September 14, 2021Unknown status
Condition(s):Lung Neoplasms; CoughLast Updated:June 25, 2018Unknown status
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:August 27, 2018Unknown status
Condition(s):Lung Cancer; Lung Cancer MetastaticLast Updated:January 13, 2020Completed
Condition(s):Main Hypothesis is That in the NASH Associated to IMIDs, to Different Phenotypes co ExistLast Updated:November 30, 2018Unknown status
Condition(s):Myelodysplastic SyndromesLast Updated:September 11, 2019Completed
Condition(s):Advanced Gastric CarcinomaLast Updated:April 28, 2022Not yet recruiting
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:December 31, 2020Terminated
Condition(s):Myelofibrosis; AnemiaLast Updated:July 20, 2022Completed
Condition(s):Cirrhosis; Cirrhosis, Liver; Cirrhosis Early; Cirrhosis Due to Hepatitis B; Cirrhosis Advanced; Cirrhosis Infectious; Cirrhosis Alcoholic; Cirrhosis, Biliary; Cirrhosis Cryptogenic; Cirrhosis Due to Hepatitis C; Cirrhosis Due to Primary Sclerosing CholangitisLast Updated:January 10, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.